Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > The evidence is clear

<< Previous

Bullboard Posts

Next >>

Comment by ENEMENEMYNEMOon May 22, 2024 3:58pm

75 Views

Post# 36052677

RE:RE:RE:RE:RE:RE:The evidence is clear

I'm working on decorating that 2 bedroom you have in my head first. CanFan is complicit, he has mellowed over the years, he pumped this hard 5-10 years ago. I'm here to ride the hysteria, not waiting for that buyout ( sorry pause to laugh).

Biotech is worse than gambling, like CanFan said less than 10% hit the mark, so yeah I've got lots of losers but can already retire on MDNA, this is just for fun

Nothing wrong in warning the newbies to stay clear

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024